FDA Retires Monovalent COVID-19 Vaccines
The U.S. Food and Drug Administration has amended the emergency use authorizations of the. Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines to simplify the vaccination schedule for most individuals.
COVID-19 Year Three: How Medical Professionals Can Balance Life, Family and Practice
Is finding a healthy work-life balance possible in the post-pandemic world?
New Test Identifies Patients at Risk of Severe COVID-19
U.S. scientists have developed a new genomic test that can predict a patient’s risk of developing severe COVID-19, an advance that could help doctors quickly begin tailored treatment.
Combination COVID-19 and Influenza Vaccine Under Development
Despite technical challenges, some companies are working on making a combination COVID and flu vaccine.
Vaccine Passports: Vaccination Confirmation or a Privacy Concern?
The implementation of vaccine passports in response to the COVID-19 pandemic has raised arguments for and against them.
IVIG Plus Glucocorticoids Superior to IVIG Alone for MIS-C Associated with COVID-19: Review and Meta-Analysis
A new systematic review and meta-analysis conducted by U.S. and Nepalese collaborators supports the use of IVIG with glucocorticoids compared to IVIG alone.
Scientists Are Developing Cheaper, Patent-Free and Easier-to-Make COVID Vaccine
Researchers at the Texas Children’s Hospital Center for Vaccine Development at Baylor College of Medicine are developing a COVID-19 vaccine using a conventional method that will make the production and distribution cheaper and more accessible.
Immunity Debt: A Catalyst for the Development of Infections and Autoimmune Disease?
Are precautions to stop the spread of COVID-19 now causing other widespread illness?
Implementing Stringent Cleaning and Disinfecting Policies in the Healthcare Setting
Loosening of COVID-19 restrictions in healthcare facilities requires stringent cleanliness policies to curb the spread of infection.
Advances in Diagnostic Testing for Antimicrobial Resistance
The threat of antimicrobial resistance has increased substantially since the start of the COVID-19 pandemic, and while a host of diagnostic tools are available, these life-threatening infections still pose a threat due to limitations of tests, especially those that are rapid.
